Corrigendum to: High Body Mass Index is Correlated with the Success of Vonoprazan-Based Second-Line Therapy for Helicobacter Pylori Infection (Tohoku J. Exp. Med., 253, 85-94, 2021, 10.1620/tjem.253.85)

In the version of this article published in the February issue, 2021, the author mistook the affiliation of the first author. The correct affiliation of Toyotaka Kasai is Department of Gastroenterology, Fukaya Red Cross Hospital, Fukaya, Saitama, Japan and Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan. Concerning the “Table 1” (Page 91) of this article, the authors found that the sex item was missing. Table 1 added sex item is the next page. The authors sincerely apologize for the oversight on this matter.